Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Dec 6;5(1):137-140.
doi: 10.1016/j.jaccao.2022.10.009. eCollection 2023 Feb.

The European Society of Cardiology Cardio-Oncology Guidelines: Evidence Base, Actionability, and Relevance to Clinical Practice

Affiliations
Editorial

The European Society of Cardiology Cardio-Oncology Guidelines: Evidence Base, Actionability, and Relevance to Clinical Practice

Darryl P Leong et al. JACC CardioOncol. .
No abstract available

Keywords: epidemiology; guidelines; outcomes.

PubMed Disclaimer

Conflict of interest statement

Dr Leong has received consultancy and speaker fees from Abbvie, Ferring Pharmaceuticals, Janssen, Myovant Sciences, Novartis, Pfizer, Sanofi, Tolmar, AstraZeneca, and Paladin related to prostate and myeloproliferative neoplasm cardio-oncology; and research support from Novartis. Dr Mukherjee has reported that he has no relationships relevant to the contents of this paper to disclose.

References

    1. Lyon A.R., López-Fernández T., Couch L.S., et al. 2022 ESC guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS) Eur Heart J. 2022;43(41):4229–4361. doi: 10.1093/eurheartj/ehac244. - DOI - PubMed
    1. Ky B. JACC: CardioOncology: poised to serve a maturing, collaborative field. J Am Coll Cardiol CardioOnc. 2019;1:131–132. - PMC - PubMed
    1. Cardinale D., Colombo A., Lamantia G., et al. Cardio-oncology: a new medical issue. Ecancermedicalscience. 2008;2:126. doi: 10.3332/ecancer.2008.126. - DOI - PMC - PubMed
    1. Slamon D., Eiermann W., Robert N., et al. Adjuvant trastuzumab in HER2-positive breast cancer. N Engl J Med. 2011;365:1273–1283. - PMC - PubMed
    1. Thavendiranathan P., Negishi T., Somerset E., et al. Strain-guided management of potentially cardiotoxic cancer therapy. J Am Coll Cardiol. 2021;77:392–401. - PubMed

Publication types